2016 European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery Mechanism / Preclinical Unspecified
2016 · Mohamed — Antioxidants and K⁺ Channel Agonists versus Hydrogen Therapy during Ex Vivo Lung Perfusion
Super-Abstract
This study compared different protective strategies — antioxidants, potassium channel agonists, and hydrogen therapy — applied during ex-vivo lung perfusion (EVLP), a technique used to preserve and assess donor lungs before transplantation. The study was conducted in an animal (non-human) system; the abstract is not publicly available in this record. (European Journal of Cardio-Thoracic Surgery, 2016.)
Commentary
Ex-vivo lung perfusion (EVLP) is a clinically relevant technique for reconditioning marginal donor lungs before transplantation — improving preservation and allowing assessment of lung function outside the body. Ischemia-reperfusion injury and oxidative stress during EVLP are major problems limiting transplant success. Mohamed et al. appear to compare antioxidant strategies and potassium channel agonists against hydrogen-based therapy in this ex-vivo setting. The subject coding (animal, ev=1) indicates this is a preclinical study. The abstract is not available in this database record, preventing a detailed evaluation of methods, results, or specific findings. The DOI (10.1093/ejcts/ezv192) should be consulted for the full study. No human transplant efficacy conclusions can be drawn from this record.
Key quotes
- „Antioxidants and K+ channel agonists versus hydrogen therapy during ex vivo lung perfusion.“ — the study's comparative design as stated in the title — full abstract unavailable
Our assessment
This is a preclinical ex-vivo animal lung study — not a human transplant trial. The abstract is absent from this database record, making a full scientific assessment impossible here. The comparison of hydrogen therapy against alternative protective strategies in the EVLP context is clinically relevant as a research question, but results cannot be evaluated without the full text. No conclusions about H₂'s clinical use in lung transplantation can be drawn from this record. The full paper is accessible via DOI 10.1093/ejcts/ezv192.
Study design
- Type: preclinical animal study, ex-vivo lung perfusion model · Model: animal lungs (species not specified in available record) · Comparison: antioxidants vs. K⁺ channel agonists vs. hydrogen therapy during EVLP
- Result: not evaluable from this record — abstract is empty; full paper required
Source & links
Screenshot of the PubMed page
This page mirrors the published abstract (© the authors / publisher) for reference and citation. The canonical source is the PubMed record linked above. This is not medical advice.